Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | RARB | P10826 | 6/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17847499 | 1.00 | PSMB5 (0.45) | PSMB5GPR3RARBKAT8HSD11B1 | |
| SCHEMBL28173859 | 0.99 | PSMB5 (0.46) | PSMB5GPR3RARBKAT8HSD11B1 | |
| SCHEMBL17847497 | 0.95 | PSMB5 (0.50) | PSMB5GPR3RARBHSD11B1ALDH1A1 | |
| SCHEMBL19713048 | 0.89 | CNR2 (0.40) | PSMB5ALDH1A1 | |
| SCHEMBL17847511 | 0.83 | ALDH1A1 (0.44) | PSMB5ALDH1A1MAPT | |
| SCHEMBL28472275 | 0.81 | BACE1 (0.38) | PSMB5ALDH1A1 | |
| SCHEMBL11385174 | 0.81 | PSMB5 (0.49) | PSMB5GPR3RARBKAT8HSD11B1 | |
| SCHEMBL22318919 | 0.80 | MMP12 (0.40) | PSMB5ALDH1A1 | |
| SCHEMBL28899630 | 0.78 | PPARA (0.55) | KAT8PPARAALDH1A1 | |
| SCHEMBL17847496 | 0.77 | FOLH1 (0.49) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107223121-B | Wet stable holographic media | 科思创德国股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3233791-B1 | MOISTURE STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2020-08-12 | — | — | EP | disclosed |
| US-10329244-B2 | Moisture-stable holographic media | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
| EP-3233791-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | Covestro Deutschland AG (DE) | 2017-10-25 | — | — | EP | disclosed |
| CN-107223121-A | Wet stable holographic media | 科思创德国股份有限公司 | 2017-09-29 | — | — | CN | disclosed |
| WO-2016096641-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329244-B2 | Moisture-stable holographic media | NEFM, MDM4, BHMT2 | PSMB5 2023/4885GPR3 4747/4885RARB 4325/4885 |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | NEFM, MDM4, BHMT2 | PSMB5 2023/4885GPR3 4747/4885RARB 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.